GROUPE ATHENA, INC
MUMBAI, INDIA, United States, via ETELIGIS INC., 06/12/2015 – – Groupe Athena, Inc. (OTC Pink: GATA) (PINKSHEETS: GATA) announced today that it is one of 3 companies nominated for the prestigious CFI.co award for best pharmaceutical consultancy company from India. The final award will be announced by end July, 2015.
CFI.co, a print journal and online resource, headquartered in London, reports on business, economics and finance, recognizing the fact that the traditional distinction between emerging and developed markets is now far less meaningful as world economies converge. The nomination follows voting from readers, subscribers and contributors such as the World Bank Group (including the IFC) and various UN organizations, EU bodies and other prominent entities.
Reacting to the nomination, the Company’s Chairman, D. Purohit stated, “We are honored and humbled by this prestigious nomination and will continue to work towards maximizing shareholder value whilst serving our clients to the best of our ability”.
About Groupe Athena, Inc.:
Groupe Athena, Inc. was incorporated in June 2008 and began operations on July 1 of that year. The company is a research and testing organization and helps various pharmaceutical and medical products and devices companies in India and Southeast Asia to get regulatory approvals and facilitate exports of their products to the United States. The Company accomplishes this by assisting clients from concept through development, providing consultation on regulatory requirements, filings and processes.
The company has a research and marketing facility in India that employs 22 consultants and marketing personnel and is working towards aggressively expanding its presence in the Indian pharmaceutical industry. The Company’s web address is www.groupeathena.com.
Safe Harbor Statement:
Certain statements set forth in this press release constitute "forward-looking statements.” Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate", "project", "intend", "forecast", "anticipate", "plan", "planning", "expect", "believe", "will likely", "should", "could", "would", "may" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company’s actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company’s ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company’s limited operating history, the limited financial resources, domestic or global economic conditions — activities of competitors and the presence of new or additional competition and conditions of equity markets.
For more information contact:
Groupe Athena, Inc.
SOURCE: Groupe Athena, Inc.